 |
|
|
|
|
|
|
|
 |
|
||||||
 |
 |
 |
 |
 |
 |
 |
|
Analyst Conference Summaries
BioLineRx
BLRX
conference date: March 31, 2025 @ 5:30 AM Pacific Time
| 2025 | |||
| BioLineRx BLRX Q1 2025 |
|||
| May 27, 2025 | |||
| 2024 | |||
| BioLineRx BLRX Q1 2024 |
BioLineRx BLRX Q2 2024 |
BioLineRx BLRX Q3 2024 |
BioLineRx BLRX Q4 2024 |
| May 28, 2024 | Aug. 15, 2024 | Nov. 25, 2024 | March 31, 2025 |
| 2023 | |||
| BioLineRx BLRX Q3 2023 |
BioLineRx BLRX Q4 2023 |
||
| Nov. 20, 2023 | Mar. 26, 2024 | ||
Biolinerx (BLRX) is a recently commercial stage biotechnology company specializing in therapies for stem cell mobilization to combine with cancer therapies.
More Analyst Conference Pages:
| AGEN |
| AGIO |
| ALLO |
| ALNY |
| AMAT |
| AMGN |
| APRE |
| ARWR |
| BIIB |
| BMY |
| CLDX |
| CDTX |
| GILD |
| GLYC |
| ILMN |
| IMGN |
| INCY |
| INKT |
| INO |
| IONS |
| MCHP |
| MRNA |
| PLX |
| REGN |
| RNA |
| RXRX |
| SAGE |
| SANA |
| VSTM |
| VRTX |
Disclaimer: My analyst summaries may include both condensations of statements made by company representatives and my own analysis. They are not covered by any warranty. I cannot guarantee anything said by company representatives is true. I try not to make errors, but it is possible. These are my personal notes which I share with other investors and which I use as the basis of my blog and Seeking Alpha articles.
Copyright 2025 William P. Meyers